We were very pleased with our choice to engage innoVitro’s contractility service. The studies using human iPSC-derived cardiomyocytes were tailored to our needs to provide results comparable to already existing (in house) data and the fast execution followed by a comprehensive study report completed the service perfectly.
News
- Get your free download of our most recent article published in the “Journal of Pharmacological and Toxicological Methods” here!Click on the following link to download the article “Integration of mechanical conditioning […]
- innoVitro is a founding member of the Botanical Safety ConsortiumWe are happy to announce our membership of the Botanical Safety Consortium (BSC)! The BSC is a […]
- FLEXcyte Grant Winners 2020The winners of the 2020 FLEXcyte Grant were finally announced![…]
- Post date August 20, 2020